Over the last few years, changes have taken place in the NHS at both regional and national levels and these changes can impact product success at a global level. Understanding this changing environment is vital to those working in pharmaceutical market research looking to support clients in their own decision-making.
After years of conducting pharmaceutical market research with key stakeholders within the NHS, we’ve built up a highly responsive panel of specialist respondents, including hundreds of NHS payers.
The types of payers we can recruit include:
Medicines Management and Optimisation
Head of Commissioning
Key Opinion Leaders
Hospital Business Managers
Head of Long Term Conditions
Representatives from CCGs
The NHS can be complex and trying to understand who is responsible for which services, what influence they have and who we can access for pharmaceutical market research can be difficult. Why not download our NHS guide that can help you get a top line overview of the NHS commissioning structure as well as:
Who's who in the process
Who we can access for market research
Although we've all been affected by the COVID-19 outbreak, GKA wants to assure you that our team is fully operational and here to support our valued partners with their medical market research as we all adapt and find new ways to progress forward.
Clearly these are challenging times but, from the most recent research we carried out with our own panel of healthcare professionals, things are beginning to improve with indications being that all forms of medical market research, including face-to-face, will be achievable in the not-too-distant future.
If you’d like the results of that research, or we can support you in any way at the moment, please contact us at email@example.com. We’re here and ready to help.